ANIX
Price
$4.85
Change
+$0.65 (+15.48%)
Updated
Dec 3 closing price
Capitalization
159.65M
34 days until earnings call
Intraday BUY SELL Signals
PHVS
Price
$29.36
Change
+$5.24 (+21.72%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.69B
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANIX vs PHVS

Header iconANIX vs PHVS Comparison
Open Charts ANIX vs PHVSBanner chart's image
Anixa Biosciences
Price$4.85
Change+$0.65 (+15.48%)
Volume$580.61K
Capitalization159.65M
Pharvaris
Price$29.36
Change+$5.24 (+21.72%)
Volume$26.45K
Capitalization1.69B
ANIX vs PHVS Comparison Chart in %
ANIX
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANIX vs. PHVS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a StrongBuy and PHVS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ANIX: $4.22 vs. PHVS: $24.18)
Brand notoriety: ANIX and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 34% vs. PHVS: 62%
Market capitalization -- ANIX: $144.83M vs. PHVS: $1.69B
ANIX [@Biotechnology] is valued at $144.83M. PHVS’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while PHVS’s TA Score has 6 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 2 bearish.
  • PHVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -2.43% price change this week, while PHVS (@Biotechnology) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ANIX is expected to report earnings on Jan 07, 2026.

PHVS is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.69B) has a higher market cap than ANIX($160M). ANIX YTD gains are higher at: 81.681 vs. PHVS (26.135). ANIX has higher annual earnings (EBITDA): -11.95M vs. PHVS (-165.21M). PHVS has more cash in the bank: 200M vs. ANIX (16M). ANIX has less debt than PHVS: ANIX (213K) vs PHVS (634K). ANIX (0) and PHVS (0) have equivalent revenues.
ANIXPHVSANIX / PHVS
Capitalization160M1.69B9%
EBITDA-11.95M-165.21M7%
Gain YTD81.68126.135313%
P/E RatioN/AN/A-
Revenue00-
Total Cash16M200M8%
Total Debt213K634K34%
FUNDAMENTALS RATINGS
ANIX: Fundamental Ratings
ANIX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANIXPHVS
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
85%
Momentum
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
84%
MACD
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 6 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSBPX32.42N/A
N/A
Principal SmallCap R5
GQETX37.44N/A
N/A
GMO Quality III
VLCGX18.23N/A
N/A
VALIC Company I Large Cap Core
EMAAX17.21N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
MGOYX13.87N/A
N/A
Victory Mid-Cap Core Growth Y

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with ZBIO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then ZBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-4.20%
ZBIO - ANIX
33%
Loosely correlated
-7.07%
KLTO - ANIX
31%
Poorly correlated
+0.51%
GLTO - ANIX
30%
Poorly correlated
+7.37%
PHVS - ANIX
30%
Poorly correlated
-7.00%
NUVL - ANIX
30%
Poorly correlated
-1.37%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-7.00%
INKT - PHVS
36%
Loosely correlated
-2.07%
NUVL - PHVS
34%
Loosely correlated
-1.37%
MGTX - PHVS
33%
Poorly correlated
-1.21%
HOWL - PHVS
31%
Poorly correlated
-6.05%
CELC - PHVS
30%
Poorly correlated
-1.01%
More